Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01293032
What this trial is testing

Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituStage II Breast Cancer+4 more
Virginia Commonwealth University 59
Testing effectiveness (Phase 2)UnknownNCT00348998
What this trial is testing

Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Virginia Mason Hospital/Medical Center 18
Very early researchActive Not RecruitingNCT03044977
What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting
David Bushnell 20
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Large-scale testing (Phase 3)UnknownNCT01579734
What this trial is testing

Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users

Who this might be right for
Breast Cancer
European Institute of Oncology 1,884
Not applicableLooking for participantsNCT06050109
What this trial is testing

The Benefits of Continued Use of Ovarian Function Suppression After 5 Years

Who this might be right for
Breast Cancer FemaleEndocrine Therapy
Hongmei Zheng, PhD 1,200
Not applicableStudy completedNCT00260975
What this trial is testing

Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 112
Testing effectiveness (Phase 2)Active Not RecruitingNCT00585507
What this trial is testing

Efficacy and Safety of 500mg of Fulvestrant

Who this might be right for
Breast Cancer
Beth Israel Deaconess Medical Center 40
Not applicableStudy completedNCT02707471
What this trial is testing

Improving Well-Being for Breast Cancer Patients

Who this might be right for
Self-management Intervention (SM-AET)General Health Education
Duke University 312
Large-scale testing (Phase 3)Looking for participantsNCT06757634
What this trial is testing

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

Who this might be right for
Breast Cancer
Celcuity Inc 1,180
Early research (Phase 1)Active Not RecruitingNCT01327781
What this trial is testing

Z-Endoxifen Hydrochloride in Treating Patients With Metastatic or Locally Recurrent Estrogen Receptor-Positive Breast Cancer

Who this might be right for
HER2/Neu PositiveRecurrent Breast CarcinomaStage IIIC Breast Cancer AJCC v7+1 more
National Cancer Institute (NCI) 62
Testing effectiveness (Phase 2)Study completedNCT00537836
What this trial is testing

ZK283197 for Treatment of Vasomotor Symptoms

Who this might be right for
Vasomotor System
Bayer 116
Testing effectiveness (Phase 2)Study completedNCT04332744
What this trial is testing

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Who this might be right for
Metastatic Prostate Cancer
MedSIR 54
Not applicableStudy completedNCT06307457
What this trial is testing

HR+/HER2- Metastatic Breast Cancer Patients Treated With Palbociclib Together With an Aromatase Inhibitor From 2017 to 2023 in Denmark.

Who this might be right for
Breast Cancer
Pfizer 604
Testing effectiveness (Phase 2)Study completedNCT01589367
What this trial is testing

Neoadjuvant Letrozole Plus Metformin vs Letrozole Plus Placebo for ER-positive Postmenopausal Breast Cancer

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Seoul National University Hospital 208
Large-scale testing (Phase 3)Study completedNCT00294164
What this trial is testing

Safety and Efficacy Trial of Serostim® in the Treatment of Subjects With Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)

Who this might be right for
Human Immunodeficiency Virus-associated Adipose Redistribution Syndrome (HARS)Human Immunodeficiency Virus Infections
EMD Serono 245
Not applicableUnknownNCT06061666
What this trial is testing

Treatment of Insomnia in Patients With Breast Cancer

Who this might be right for
Breast CancerInsomnia
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04493853
What this trial is testing

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Who this might be right for
Hormone-Sensitive Prostate Cancer
AstraZeneca 1,012
Not applicableStudy completedNCT00820001
What this trial is testing

Resources to Enhance the Adjustment of Children (REACH)

Who this might be right for
Oppositional Defiant DisorderConduct DisorderAttention Deficit Hyperactivity Disorder
University of Pittsburgh 254
Post-approval studies (Phase 4)Ended earlyNCT01345812
What this trial is testing

Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.

Who this might be right for
Patients for In Vitro Fertilization(IVF)Treatment
University of Aarhus 291
Next Page